{
  "ticker": "OSX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968852",
  "id": "02968852",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250714",
  "time": "0825",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpl0gdz4qpr.pdf",
  "summary": "- **Regulatory Approval**: Osteopore secures Swiss market approval under EU Medical Device Regulation (MDR), completing its product portfolio for Switzerland and Europe.  \n- **Partnership**: Strengthens distribution via exclusive agreement with Zimmer Biomet for EMEA, APAC, Australia, and New Zealand.  \n- **Market Opportunity**: European cranial implant market projected to reach ~USD 527.6M by 2027, with custom implants as the largest segment.  \n\n*No material trading or capital markets impacts identified (e.g., no raise, no financial data).*",
  "usage": {
    "prompt_tokens": 1567,
    "completion_tokens": 117,
    "total_tokens": 1684,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-13T22:34:42.694531"
}